Review findings

Start the 7-step beginner guide Peptides Side Effects New Directory Learn Tools Blog News About Sermorelin 📋 Overview 🧬 Molecule 🔄 Similar ⚠️ Side Effects 💉 Dosing 🔬 Research 🚨 Risks 👥 Community 📊 Community Data Home Peptides Sermorelin Growth Hormone Anti-Aging & Longevity approved Sermorelin Also known as: GRF 1-29, GHRH(1-29), Geref, Sermorelin Acetate Compare with 3 peptide s Research compiled by Peptide Protocol Wiki 📅 Updated February 8, 2026 Citations Verified TL;DR Sermorelin is a synthetic 29-amino acid peptide corresponding to the first 29 amino acids of endogenous GHRH (growth hormone-releasing hormone).

Restore access No thanks, continue reading Related Reading Peptide Ipamorelin selective growth hormone secretagogue Peptide Tesamorelin GHRH analog peptide Peptide CJC-1295 No DAC (Mod GRF 1-29) GHRH analog How Sermorelin works at the cellular level Overview of Sermorelin benefits and applications Scientific Details Molecular Formula C149H246N44O42S Molecular Weight 3357.88 Da CAS Number 86168-78-7 Sequence Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 What is Sermorelin? # Sermorelin (also known as GRF 1-29 or GHRH(1-29)NH2) is a synthetic peptide analog consisting of the first 29 amino acids of the naturally occurring 44-amino acid growth hormone-releasing hormone (GHRH).

al GH pulse → Often combined with ipamorelin (100-300 mcg) for synergistic GHRH+GHRP effect → 5 days on, 2 days off is a common schedule to prevent desensitization → Obesity reduces GH response and may require higher doses → Contraindication: Avoid with active malignancy or history of cancer; caution in diabetes; not for use with active intracranial lesions Subscribe to unlock this content Get weekly peptide research summaries, new study alerts, and protocol updates — free.

Restore access No thanks, continue reading Related Reading Peptide Ipamorelin selective growth hormone secretagogue Peptide Tesamorelin GHRH analog peptide Peptide CJC-1295 No DAC (Mod GRF 1-29) GHRH analog How Sermorelin works at the cellular level Overview of Sermorelin benefits and applications Scientific Details Molecular Formula C149H246N44O42S Molecular Weight 3357.88 Da CAS Number 86168-78-7 Sequence Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 What is Sermorelin? # Sermorelin (also known as GRF 1-29 or GHRH(1-29)NH2) is a synthetic peptide analog consisting of the first 29 amino acids of the naturally occurring 44-amino acid growth hormone-releasing hormone (GHRH).

For wellness research, anti-aging applications, and lower-risk GH optimization, Sermorelin is the more evidence-supported and safety-conscious choice. → Sermorelin vs Ipamorelin Sermorelin has stronger clinical evidence, including former FDA approval and well-established dosing protocols.

Peptide Protocol Wiki March 7, 2026 BPC-157 TB-500 AOD-9604 + 11 more You Might Also Like Related content you may find interesting Peptide Growth Hormone Ipamorelin Peptide Growth Hormone HGH 191AA Peptide Growth Hormone Tesamorelin Peptide Growth Hormone CJC-1295 DAC Table of Contents What is Sermorelin?

Clinical History and Regulatory Status # Sermorelin has a well-documented clinical history spanning several decades: 1980s : GHRH(1-29) was synthesized and characterized as the minimal active fragment of GHRH 1997 : FDA approved sermorelin acetate (Geref Diagnostic) for evaluation of pituitary GH secretory capacity 1997 : FDA also approved Geref for treatment of idiopathic growth hormone deficiency in children 2008 : Sermorelin products were voluntarily withdrawn from the U.S. market due to manufacturing difficulties with the active pharmaceutical ingredient, not due to safety concerns The withdrawal was purely supply-related, and sermorelin continues to be available through compounding pharmacies in the United States.

Browse all growth hormone peptides → Table of Contents 📌 TL;DR • Stimulates endogenous GH release through the physiological GHRH receptor • Previously FDA-approved for GH deficiency diagnosis (Geref) • Maintains normal GH pulsatility and feedback mechanisms • Synergistic effects when combined with GHRP peptides like ipamorelin Community-Reported Side Effects Anecdotal ?

Peptide Protocol Wiki March 14, 2026 BPC-157 TB-500 Ipamorelin + 4 more Guide 14 min read Peptide Stacking Guide 2026: Best Combinations by Goal The definitive 2026 guide to peptide stacking organized by goal.

Evidence Gaps and Limitations # Despite its former FDA-approved status, several knowledge gaps remain: Long-term outcomes of sermorelin therapy in aging adults lack robust randomized controlled trial data Optimal dosing regimens for anti-aging applications have not been established through definitive clinical trials Head-to-head comparisons with tesamorelin (another GHRH analog currently FDA-approved) are limited The clinical significance of sermorelin-induced IGF-1 increases in elderly pop

Synergistic Combinations # Sermorelin is frequently studied in combination with growth hormone-releasing peptides (GHRPs) such as ipamorelin and GHRP-2 .

ate through complementary pathways (GHRH vs GHRP) and are frequently studied in combination for synergistic GH release greater than either alone. → Sermorelin vs Tesamorelin Tesamorelin for proven metabolic indications with active FDA approval; sermorelin for broader GH research and combined GHRH/GHRP protocols through compounding access → Related Articles Guide 9 min read Best Growth Hormone Peptides Ranked: 2026 Evidence-Based Guide A ranked comparison of 8 growth hormone secretagogues and related peptides — from FDA-approved tesamorelin to IGF-1 LR3 — evaluating each on mechanism of action, clinical evidence strength, key advantages, and known drawbacks.

Peptide Protocol Wiki March 14, 2026 Tesamorelin Sermorelin Ipamorelin + 5 more Guide 12 min read Understanding Peptide Side Effects: A Comprehensive Safety Guide A thorough, evidence-based guide to peptide side effects by category — covering GLP-1 agonists, GH secretagogues, tissue repair peptides, and melanocortins — with serious risk flags, drug interactions, monitoring recommendations, and guidance on when to stop.

Peptide Protocol Wiki March 14, 2026 Semaglutide Tirzepatide BPC-157 + 3 more Guide 8 min read Peptide Stacking Safety: Synergies, Interactions, and Protocol Design A safety-focused guide to combining peptides — covering known synergistic combinations, contraindicated pairings, timing and administration principles, recommended bloodwork monitoring, and red flags to watch for during st

Peptide Protocol Wiki March 14, 2026 BPC-157 TB-500 Ipamorelin + 4 more Guide 14 min read Peptide Stacking Guide 2026: Best Combinations by Goal The definitive 2026 guide to peptide stacking organized by goal.

Peptide Protocol Wiki March 7, 2026 BPC-157 TB-500 AOD-9604 + 11 more You Might Also Like Related content you may find interesting Peptide Growth Hormone Ipamorelin Peptide Growth Hormone HGH 191AA Peptide Growth Hormone Tesamorelin Peptide Growth Hormone CJC-1295 DAC Table of Contents What is Sermorelin?

Peptide Protocol Wiki March 7, 2026 BPC-157 TB-500 AOD-9604 + 11 more You Might Also Like Related content you may find interesting Peptide Growth Hormone Ipamorelin Peptide Growth Hormone HGH 191AA Peptide Growth Hormone Tesamorelin Peptide Growth Hormone CJC-1295 DAC Table of Contents What is Sermorelin?

📋 Protocol Quick-Reference Growth hormone stimulation for anti-aging, body composition, and sleep quality improvement 💉 Dosing Amount 200-300 mcg Frequency Once daily at bedtime, 5 nights per week Duration 3-6 months, cyclical (on/off periods) 💊 Administration Route SC Schedule Once daily at bedtime, 5 nights per week Timing 30 minutes before bedtime on an empty stomach (minimum 90-minute fast before injection) ✓ Rotate injection sites 📅 Cycle Duration 3-6 months, cyclical (on/off periods) Repeatable Yes Preparation & Storage Diluent: Bacteriostatic water Use within: 14 days Storage: Store lyophilized powder at controlled room temperature (20-25C) or refrigerated (2-8C).

dose: 300 mcg · cycle: on/off · timing: bedtime · frequency: Once daily · reconstitution: Bacteriostatic

Effects on Growth in Children # Clinical studies demonstrated that once-daily subcutaneous sermorelin at 30 mcg/kg body weight, administered at bedtime, effectively promotes growth in prepubertal children with idiopathic GH deficiency.

dose: 30 mcg · route: subcutaneous · timing: bedtime · frequency: daily

al GH pulse → Often combined with ipamorelin (100-300 mcg) for synergistic GHRH+GHRP effect → 5 days on, 2 days off is a common schedule to prevent desensitization → Obesity reduces GH response and may require higher doses → Contraindication: Avoid with active malignancy or history of cancer; caution in diabetes; not for use with active intracranial lesions Subscribe to unlock this content Get weekly peptide research summaries, new study alerts, and protocol updates — free.

dose: 300 mcg · cycle: 5 days on · frequency: weekly

IV sermorelin 1 mcg/kg is a specific test for GH deficiency diagnosis SC 30 mcg/kg/day at bedtime effective for growth promotion in GHD children Significant increases in height velocity sustained during 12 months treatment Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women , publish

dose: 1 mcg · route: IV · timing: bedtime

The sermorelin stimulation test involves: Intravenous administration of sermorelin at 1 mcg/kg body weight Serial blood sampling for GH levels at 15, 30, 45, and 60 minutes post-injection A normal response (GH peak above 7-10 ng/mL) indicates intact pituitary somatotroph function A blunted response suggests pituitary-level dysfunction This test proved more specific than other provocative GH tests, with fewer false-positive results in children without true GH deficiency.

dose: 1 mcg · route: Intravenous

Peptide Directory All Peptides Metabolic Anti-Obesity Anti-Aging Immune Hormonal View All Categories Directory Peptide Vendors Analytics Labs Side Effects Database Report a Side Effect Learn

Sermorelin: GHRH Analog Research Guide | Peptide Protocol Wiki Skip to main content 🧬 Peptide Protocol Wiki Peptides Side Effects New Learn Directory Tools Blog News About ⌘K ⌘K 🌱 New to Peptides?

Start the 7-step beginner guide Peptides Side Effects New Directory Learn Tools Blog News About Sermorelin 📋 Overview 🧬 Molecule 🔄 Similar ⚠️ Side Effects 💉 Dosing 🔬 Research 🚨 Risks 👥 Community 📊 Community Data Home Peptides Sermorelin Growth Hormone Anti-Aging & Longevity approved Sermorelin Also known as: GRF 1-29, GHRH(1-29), Geref, Sermorelin Acetate Compare with 3 peptide s Research compiled by Peptide Protocol Wiki 📅 Updated February 8, 2026 Citations Verified TL;DR Sermorelin is a synthetic 29-amino acid peptide corresponding to the first 29 amino acids of endogenous GHRH (growth hormone-releasing hormone).

Browse all growth hormone peptides → Table of Contents 📌 TL;DR • Stimulates endogenous GH release through the physiological GHRH receptor • Previously FDA-approved for GH deficiency diagnosis (Geref) • Maintains normal GH pulsatility and feedback mechanisms • Synergistic effects when combined with GHRP peptides like ipamorelin Community-Reported Side Effects Anecdotal ?

This self-regulating mechanism prevents supraphysiological GH levels and reduces the risk of adverse effects associated with exogenous GH administration.

elease GH secretagogues may complement testosterone therapy for body composition Related Reading # Sermorelin research studies and evidence Sermorelin dosing protocols Sermorelin side effects profile GHRP-2 research guide Hexarelin research guide Stay current on Sermorelin research We summarize new studies, safety updates, and dosing insights — delivered biweekly.

Sermorelin preserves the body's feedback mechanisms and has a lower risk of GH-related side effects.

What are sermorelin side effects?

Common side effects include injection site reactions (redness, swelling), facial flushing, headache, and dizziness.

Serious side effects are rare.

It preserves the natural pulsatile GH release pattern, has a more favorable side effect profile, and avoids the pituitary suppression associated with exogenous GH.

Peptide Protocol Wiki March 14, 2026 Tesamorelin Sermorelin Ipamorelin + 5 more Guide 12 min read Understanding Peptide Side Effects: A Comprehensive Safety Guide A thorough, evidence-based guide to peptide side effects by category — covering GLP-1 agonists, GH secretagogues, tissue repair peptides, and melanocortins — with serious risk flags, drug interactions, monitoring recommendations, and guidance on when to stop.

Covers GHS-R1a and CD36 binding, potent GH release, dosing, and side effects.

Peptide Protocol Wiki March 14, 2026 Tesamorelin Sermorelin Ipamorelin + 5 more Guide 12 min read Understanding Peptide Side Effects: A Comprehensive Safety Guide A thorough, evidence-based guide to peptide side effects by category — covering GLP-1 agonists, GH secretagogues, tissue repair peptides, and melanocortins — with serious risk flags, drug interactions, monitoring recommendations, and guidance on when to stop.

Peptide Protocol Wiki March 14, 2026 Semaglutide Tirzepatide BPC-157 + 3 more Guide 8 min read Peptide Stacking Safety: Synergies, Interactions, and Protocol Design A safety-focused guide to combining peptides — covering known synergistic combinations, contraindicated pairings, timing and administration principles, recommended bloodwork monitoring, and red flags to watch for during st

Peptide Protocol Wiki March 14, 2026 Semaglutide Tirzepatide BPC-157 + 3 more Guide 8 min read Peptide Stacking Safety: Synergies, Interactions, and Protocol Design A safety-focused guide to combining peptides — covering known synergistic combinations, contraindicated pairings, timing and administration principles, recommended bloodwork monitoring, and red flags to watch for during st

al GH pulse → Often combined with ipamorelin (100-300 mcg) for synergistic GHRH+GHRP effect → 5 days on, 2 days off is a common schedule to prevent desensitization → Obesity reduces GH response and may require higher doses → Contraindication: Avoid with active malignancy or history of cancer; caution in diabetes; not for use with active intracranial lesions Subscribe to unlock this content Get weekly peptide research summaries, new study alerts, and protocol updates — free.

Restore access No thanks, continue reading Related Reading Peptide Ipamorelin selective growth hormone secretagogue Peptide Tesamorelin GHRH analog peptide Peptide CJC-1295 No DAC (Mod GRF 1-29) GHRH analog How Sermorelin works at the cellular level Overview of Sermorelin benefits and applications Scientific Details Molecular Formula C149H246N44O42S Molecular Weight 3357.88 Da CAS Number 86168-78-7 Sequence Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 What is Sermorelin? # Sermorelin (also known as GRF 1-29 or GHRH(1-29)NH2) is a synthetic peptide analog consisting of the first 29 amino acids of the naturally occurring 44-amino acid growth hormone-releasing hormone (GHRH).

Restore access No thanks, continue reading Related Reading Peptide Ipamorelin selective growth hormone secretagogue Peptide Tesamorelin GHRH analog peptide Peptide CJC-1295 No DAC (Mod GRF 1-29) GHRH analog How Sermorelin works at the cellular level Overview of Sermorelin benefits and applications Scientific Details Molecular Formula C149H246N44O42S Molecular Weight 3357.88 Da CAS Number 86168-78-7 Sequence Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 What is Sermorelin? # Sermorelin (also known as GRF 1-29 or GHRH(1-29)NH2) is a synthetic peptide analog consisting of the first 29 amino acids of the naturally occurring 44-amino acid growth hormone-releasing hormone (GHRH).

Restore access No thanks, continue reading Related Reading Peptide Ipamorelin selective growth hormone secretagogue Peptide Tesamorelin GHRH analog peptide Peptide CJC-1295 No DAC (Mod GRF 1-29) GHRH analog How Sermorelin works at the cellular level Overview of Sermorelin benefits and applications Scientific Details Molecular Formula C149H246N44O42S Molecular Weight 3357.88 Da CAS Number 86168-78-7 Sequence Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 What is Sermorelin? # Sermorelin (also known as GRF 1-29 or GHRH(1-29)NH2) is a synthetic peptide analog consisting of the first 29 amino acids of the naturally occurring 44-amino acid growth hormone-releasing hormone (GHRH).

Peptide Protocol Wiki March 14, 2026 BPC-157 TB-500 Ipamorelin + 4 more Guide 14 min read Peptide Stacking Guide 2026: Best Combinations by Goal The definitive 2026 guide to peptide stacking organized by goal.

Peptide Protocol Wiki March 7, 2026 BPC-157 TB-500 AOD-9604 + 11 more You Might Also Like Related content you may find interesting Peptide Growth Hormone Ipamorelin Peptide Growth Hormone HGH 191AA Peptide Growth Hormone Tesamorelin Peptide Growth Hormone CJC-1295 DAC Table of Contents What is Sermorelin?

Peptide Protocol Wiki March 7, 2026 BPC-157 TB-500 AOD-9604 + 11 more You Might Also Like Related content you may find interesting Peptide Growth Hormone Ipamorelin Peptide Growth Hormone HGH 191AA Peptide Growth Hormone Tesamorelin Peptide Growth Hormone CJC-1295 DAC Table of Contents What is Sermorelin?

Peptide Protocol Wiki March 7, 2026 BPC-157 TB-500 AOD-9604 + 11 more You Might Also Like Related content you may find interesting Peptide Growth Hormone Ipamorelin Peptide Growth Hormone HGH 191AA Peptide Growth Hormone Tesamorelin Peptide Growth Hormone CJC-1295 DAC Table of Contents What is Sermorelin?

Peptide Protocol Wiki March 7, 2026 BPC-157 TB-500 AOD-9604 + 11 more You Might Also Like Related content you may find interesting Peptide Growth Hormone Ipamorelin Peptide Growth Hormone HGH 191AA Peptide Growth Hormone Tesamorelin Peptide Growth Hormone CJC-1295 DAC Table of Contents What is Sermorelin?

Peptide Protocol Wiki March 7, 2026 BPC-157 TB-500 AOD-9604 + 11 more You Might Also Like Related content you may find interesting Peptide Growth Hormone Ipamorelin Peptide Growth Hormone HGH 191AA Peptide Growth Hormone Tesamorelin Peptide Growth Hormone CJC-1295 DAC Table of Contents What is Sermorelin?

Peptide Protocol Wiki March 7, 2026 BPC-157 TB-500 AOD-9604 + 11 more You Might Also Like Related content you may find interesting Peptide Growth Hormone Ipamorelin Peptide Growth Hormone HGH 191AA Peptide Growth Hormone Tesamorelin Peptide Growth Hormone CJC-1295 DAC Table of Contents What is Sermorelin?

Peptide Protocol Wiki March 7, 2026 BPC-157 TB-500 AOD-9604 + 11 more You Might Also Like Related content you may find interesting Peptide Growth Hormone Ipamorelin Peptide Growth Hormone HGH 191AA Peptide Growth Hormone Tesamorelin Peptide Growth Hormone CJC-1295 DAC Table of Contents What is Sermorelin?

Peptide Protocol Wiki March 7, 2026 BPC-157 TB-500 AOD-9604 + 11 more You Might Also Like Related content you may find interesting Peptide Growth Hormone Ipamorelin Peptide Growth Hormone HGH 191AA Peptide Growth Hormone Tesamorelin Peptide Growth Hormone CJC-1295 DAC Table of Contents What is Sermorelin?

Peptide Protocol Wiki March 7, 2026 BPC-157 TB-500 AOD-9604 + 11 more You Might Also Like Related content you may find interesting Peptide Growth Hormone Ipamorelin Peptide Growth Hormone HGH 191AA Peptide Growth Hormone Tesamorelin Peptide Growth Hormone CJC-1295 DAC Table of Contents What is Sermorelin?

Peptide Protocol Wiki March 7, 2026 BPC-157 TB-500 AOD-9604 + 11 more You Might Also Like Related content you may find interesting Peptide Growth Hormone Ipamorelin Peptide Growth Hormone HGH 191AA Peptide Growth Hormone Tesamorelin Peptide Growth Hormone CJC-1295 DAC Table of Contents What is Sermorelin?

Peptide Protocol Wiki March 14, 2026 Tesamorelin Sermorelin Ipamorelin + 5 more Guide 12 min read Understanding Peptide Side Effects: A Comprehensive Safety Guide A thorough, evidence-based guide to peptide side effects by category — covering GLP-1 agonists, GH secretagogues, tissue repair peptides, and melanocortins — with serious risk flags, drug interactions, monitoring recommendations, and guidance on when to stop.